• Poly(I:C): Synthetic Double-Stranded RNA Analog for Immune M

  2026-07-10

  Poly(I:C) stands out as a gold-standard synthetic double-stranded RNA analog for robust TLR3 activation and dendritic cell maturation. This guide translates cutting-edge findings into high-performance workflows, troubleshooting strategies, and actionable protocol enhancements for immunology, antiviral screening, and cross-domain research.

• Palonosetron Hydrochloride in Chemotherapy-Induced Nausea Co

  2026-07-09

  Ruhlmann and Herrstedt's study provides a detailed evaluation of palonosetron hydrochloride as an advanced 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting (CINV). Their analysis highlights the drug's pharmacological distinctions, clinical effectiveness, and implications for antiemetic regimen optimization in oncology research.

• Bacterial OMV-Based mRNA Display for Personalized Tumor Vacc

  2026-07-09

  This study introduces a novel mRNA vaccine delivery platform using genetically engineered bacterial outer membrane vesicles (OMVs) to rapidly display and deliver antigen-encoding mRNA for personalized cancer immunotherapy. The approach demonstrates potent antitumor effects and long-term immune protection, offering a promising alternative to lipid nanoparticle-based mRNA vaccines.

• Trelagliptin Succinate: Beyond Diabetes—New Mechanistic Insi

  2026-07-08

  Explore how Trelagliptin succinate, a selective DPP-4 inhibitor, advances type 2 diabetes research and reveals novel osteogenic mechanisms. This article uniquely analyzes AMPK–RUNX2 signaling, practical protocols, and translational value for metabolic and bone biology studies.

• HSBP7 Modulation Rescues Titin Cardiomyopathy via Morphologi

  2026-07-08

  This study introduces CARDIO, a high-content morphological profiling method for human cardiomyocytes, to systematically identify genetic modifiers of titin-associated cardiomyopathy. The discovery that HSBP7 depletion can rescue contractile defects in titin-mutant cells reveals a new therapeutic direction for dilated cardiomyopathy.

• JNJ-10198409: Advanced Platelet-Derived Growth Factor Recept

  2026-07-07

  JNJ-10198409 delivers nanomolar precision for angiogenesis and antiproliferative research by targeting PDGF-BB receptor signaling. This guide translates the latest kinase-host interaction findings and comparative protocol insights into actionable steps for more reliable, reproducible results.

• Biomimetic Nanoplatforms for Metastatic TNBC: Photothermal a

  2026-07-07

  This study introduces an intelligent biomimetic nanoplatform that synergizes photothermal ablation with immune remodeling to address metastatic triple-negative breast cancer (TNBC). The platform demonstrates improved tumor targeting, immune activation, and suppression of recurrence and metastasis, providing a promising strategy for challenging TNBC cases.

• Leptin (116-130), amide, mouse: Applied Workflows & Troubles

  2026-07-06

  Leptin (116-130), amide, mouse, a potent adipocyte-derived hormone fragment, offers precision tools for dissecting energy homeostasis and immunometabolic signaling in obesity and diabetes research. This article delivers actionable protocols, advanced applications, and troubleshooting strategies to maximize the value and reproducibility of this APExBIO reagent.

• TMEM16F Lipid Scrambling Regulates Ferroptosis and Tumor Imm

  2026-07-06

  Yang et al. identify TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis, revealing that impairing this process sensitizes tumor cells to ferroptotic death and enhances immune rejection. These findings provide a mechanistic bridge between membrane lipid remodeling, cell death execution, and the immune response, with implications for therapeutic strategies targeting ferroptosis.

• SAFB and Major Satellite RNAs Stabilize Heterochromatin Stru

  2026-07-05

  Huo et al. (2020) reveal that the nuclear matrix protein SAFB interacts with major satellite RNAs to maintain pericentromeric heterochromatin architecture, partly via phase separation. This work illuminates how RNA-protein interactions govern 3D genome organization, with implications for transcriptional regulation and chromatin biology.

• LY-411575: Gamma-Secretase Inhibitor Workflows & Troubleshoo

  2026-07-04

  LY-411575 enables precise inhibition of gamma-secretase, empowering researchers to dissect amyloid beta and Notch signaling with high selectivity in Alzheimer's and cancer models. This guide delivers stepwise workflows, critical troubleshooting strategies, and actionable insights based on the latest immuno-oncology advances.

• CCCP: Mechanistic Insights and Assay Optimization in Mitocho

  2026-07-03

  Explore the mechanistic depth of CCCP (carbonyl cyanide m-chlorophenyl hydrazine) in mitochondrial research. This article uniquely analyzes how CCCP’s biochemical actions inform assay design and interpretation, with direct implications for neurodegenerative disease modeling.

• YM 58483 (BTP2): Precision SOCE Blockade in Fibrosis Models

  2026-07-03

  YM 58483 (BTP2) enables targeted, reproducible inhibition of SOCE, proven essential for dissecting calcium-driven fibrogenic and immune responses. Its selectivity for CRAC and TRP channels empowers precise modeling, especially in postirradiation fibrosis and T cell activation workflows.

• MCL-1’s Canonical Anti-Apoptotic Role in Breast Cancer Unvei

  2026-07-02

  A recent study clarifies that breast cancer cells rely on MCL-1 chiefly for its conventional anti-apoptotic activity. This finding strengthens the rationale for using selective MCL-1 inhibitors to induce apoptosis in MCL-1-dependent tumors and guides future therapeutic strategies.

• A40926: Dalbavancin Precursor and Potent Glycopeptide Antibi

  2026-07-02

  A40926 is a natural glycopeptide antibiotic and validated dalbavancin precursor, exhibiting low MICs against Gram-positive pathogens and Neisseria gonorrhoeae. Its mechanism of action involves D-Ala-D-Ala binding, leading to potent cell wall synthesis inhibition. This dossier details its benchmarks, applications, and integration into antibacterial research workflows.

455 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page